Letrozol Amarox (Letrozole)

Letrozole blocks the aromatase enzyme, which converts androgens into estrogens in peripheral tissues. By inhibiting this conversion, circulating estrogen concentrations fall, depriving estrogen‑dependent cancer cells of a key growth signal and thereby slowing or stopping tumor proliferation.

The dosage of Letrozol Amarox is determined by the prescribing clinician based on the patient’s condition, weight, liver function, and treatment goals. Only a qualified healthcare professional should set the dose and schedule; patients should follow the prescriber’s instructions exactly.

Letrozol Amarox is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because it can cause fetal harm. It is also not recommended while breastfeeding, as it may pass into breast milk and affect the infant. Effective contraception is required for women of child‑bearing potential.

To order Letrozol Amarox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Letrozole belongs to the aromatase inhibitor class, similar to anastrozole and exemestane. Compared with anastrozole, letrozole generally provides a slightly stronger estrogen suppression, which may translate into marginally higher response rates in some studies. Choice of agent depends on individual patient factors, tolerability, and physician preference.

Letrozol Amarox tablets should be stored at ambient temperature below 25 °C, in their original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.

Letrozol Amarox is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. Swallow the tablet whole with a glass of water; do not crush, split, or chew unless specifically instructed by a healthcare professional.

Serious risks include severe liver injury, osteoporosis‑related bone fractures, and allergic reactions such as rash, swelling, or breathing difficulty. Patients should report any signs of jaundice, persistent bone pain, or sudden allergic symptoms to their healthcare provider promptly.

Letrozol Amarox should not be used by pregnant or breastfeeding women, premenopausal patients, or individuals with known hypersensitivity to letrozole or any tablet components. Patients with severe liver impairment should also avoid the drug unless a specialist determines a benefit outweighs the risk.